Sanderling Management Company, LLC

About

Sanderling Ventures - Building new biomedical companies Dedicated to biomedical financing and active management Contact Us Dedicated to early-stage biomedical financing and active management Learn More Pulsar Vascular Intra Aneursym Implant Learn More Our Story Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. We demonstrate that significant companies are best built in close working partnerships with entrepreneurs. Check us out How We Can Help Our unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates of return for both its entrepreneurs and investors. Learn more Specialization Small molecule therapeutics Biologics and vaccines Drug delivery Platform technologies Medical devices See all Recent News March 5, 2025 - Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio Read more January 13, 2025 - Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System Read more December 30, 2024 - Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Read more

Key Contact